← FDA DRUG APPROVALS

FDA ANDA · ANDA206606

ACYCLOVIR SODIUM

Sponsor: ZYDUS PHARMS

APPLICATION
ANDA206606
TYPE
ANDA
ORIGINAL APPROVAL
2017-06-13
LATEST ACTION
2025-02-18
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ACYCLOVIR SODIUMDiscontinued
ACYCLOVIR SODIUM EQ 1GM BASE/VIAL · INJECTABLE · INJECTION
ACYCLOVIR SODIUMDiscontinued
ACYCLOVIR SODIUM EQ 500MG BASE/VIAL · INJECTABLE · INJECTION

Approval history

2025-02-18Labeling · Supplement 1 · standardAP
2017-06-13UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →